Kyoto, Japan

Junichi Matsumoto

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Tsukuba, JP (2011)
  • Kyoto, JP (2016 - 2024)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovations of Junichi Matsumoto

Introduction

Junichi Matsumoto is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of regenerative medicine and cell culture technology. With a total of 17 patents to his name, Matsumoto's work has the potential to impact various medical applications.

Latest Patents

One of Matsumoto's latest patents is a production method for neuron-like cells. This invention aims to provide a process for producing neuron-like cells from somatic cells without the need for artificial gene transfer. The process involves culturing somatic cells in the presence of specific inhibitors, which leads to the generation of neuron-like cells that are useful in regenerative medicine. Another notable patent is a cell culture instrument and processing method. This instrument is designed to detach cells at desired positions and includes a photoreactive layer that enhances its functionality.

Career Highlights

Throughout his career, Junichi Matsumoto has worked with notable organizations such as Kataoka Corporation and the National Institute of Advanced Industrial Science and Technology. His experience in these institutions has allowed him to develop innovative technologies that advance the field of cell biology.

Collaborations

Matsumoto has collaborated with esteemed colleagues, including Masami Suzuki and Norio Nishi. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Junichi Matsumoto's innovative work in producing neuron-like cells and advancing cell culture technology showcases his significant contributions to science and medicine. His patents reflect a commitment to improving regenerative medicine and cell processing methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…